An Overview of Bortezomib-Induced Neurotoxicity

about

Chemotherapy-induced neuropathies-a growing problem for patients and health care providers Toxicities of Therapeutic Agents Used in Medicine.Potential therapeutic and economic value of risk-stratified treatment as initial treatment of multiple myeloma in Europe.

P2860

Q28818565-8B777531-6A27-4980-BEF3-F23F83CA0DE2 Q42361402-E3E58627-4EBF-497C-BC90-D963B31B1BD6 Q48537667-889C0B0B-B19D-47C6-BEF2-96BE749FDC8D

P2860

An Overview of Bortezomib-Induced Neurotoxicity

Item

http://www.wikidata.org/entity/Q42361419

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

An Overview of Bortezomib-Induced Neurotoxicity

@en

An Overview of Bortezomib-Induced Neurotoxicity

@nl

type

Item

label

An Overview of Bortezomib-Induced Neurotoxicity

@en

An Overview of Bortezomib-Induced Neurotoxicity

@nl

prefLabel

An Overview of Bortezomib-Induced Neurotoxicity

@en

An Overview of Bortezomib-Induced Neurotoxicity

@nl

P1476

An Overview of Bortezomib-Induced Neurotoxicity

@en

P2093

Cristina Meregalli

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple myeloma: 2014 Update on diagnosis, risk-stratification, and management

Regulation mechanisms and signaling pathways of autophagy

Neurological adverse effects caused by cytotoxic and targeted therapies.

Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat.

A phase 2 study of bortezomib in relapsed, refractory myeloma.

Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.

Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies.

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial.

[Study on mechanism of bortezomib inducing peripheral neuropathy and the reversing effect of reduced glutathione].

Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies.

P304

294-303

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/TOXICS3030294

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282241295

http://www.w3.org/2001/XMLSchema#string

P698

29051465

http://www.w3.org/2001/XMLSchema#string

P921

neurotoxicity

P932

5606681

http://www.w3.org/2001/XMLSchema#string

An Overview of Bortezomib-Induced Neurotoxicity

about

P2860

P2860

An Overview of Bortezomib-Induced Neurotoxicity

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932